Sodium picosulphate or polyethylene glycol before elective colonoscopy in outpatients? A systematic review and meta-analysis
Carregando...
Citações na Scopus
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
BAISHIDENG PUBLISHING GROUP INC
Citação
WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, v.10, n.12, p.422-441, 2018
Resumo
AIM To determine the best option for bowel preparation [sodium picosulphate or polyethylene glycol (PEG)] for elective colonoscopy in adult outpatients. METHODS A systematic review of the literature following the PRISMA guidelines was performed using Medline, Scopus, EMBASE, Central, Cinahl and Lilacs. No restrictions were placed for country, year of publication or language. The last search in the literature was performed on November 20th, 2017. Only randomized clinical trials with full texts published were included. The subjects included were adult outpatients who underwent bowel cleansing for elective colonoscopy. The included studies compared sodium picosulphate with magnesium citrate (SPMC) and PEG for bowel preparation. Exclusion criteria were the inclusion of inpatients or groups with specific conditions, failure to mention patient status (outpatient or inpatient) or dietary restrictions, and permission to have unrestricted diet on the day prior to the exam. Primary outcomes were bowel cleaning success and/or tolerability of colon preparation. Secondary outcomes were adverse events, polyp and adenoma detection rates. Data on intention-totreat were extracted by two independent authors and risk of bias assessed through the Jadad scale. Funnel plots, Egger's test, Higgins' test (I2) and sensitivity analyses were used to assess reporting bias and heterogeneity. The meta-analysis was performed by computing risk difference (RD) using Mantel-Haenszel (MH) method with fixed-effects (FE) and random-effects (RE) models. Review Manager 5 (RevMan 5) version 6.1 (The Cochrane Collaboration) was the software chosen to perform the meta-analysis. RESULTS 662 records were identified but only 16 trials with 6200 subjects were included for the meta-analysis. High heterogeneity among studies was found and sensitivity analysis was needed and performed to interpret data. In the pooled analysis, SPMC was better for bowel cleaning [MH FE, RD 0.03, IC (0.01, 0.05), P = 0.003, I-2 = 33%, NNT 34], for tolerability [MH RE, RD 0.08, IC (0.03, 0.13), P = 0.002, I-2 = 88%, NNT 13] and for adverse events [MH RE, RD 0.13, IC (0.05, 0.22), P = 0.002, I-2 = 88%, NNT 7]. There was no difference in regard to polyp and adenoma detection rates. Additional analyses were made by subgroups (type of regimen, volume of PEG solution and dietary recommendations). SPMC demonstrated better tolerability levels when compared to PEG in the following subgroups: ""day-before preparation"" [MH FE, RD 0.17, IC (0.13, 0.21), P < 0.0001, I-2 = 0%, NNT 6], "" preparation in accordance with time interval for colonoscopy"" [MH RE, RD 0.08, IC (0.01, 0.15), P = 0.02, I-2 = 54%, NNT 13], when compared to ""high-volume PEG solutions"" [MH RE, RD 0.08, IC (0.01, 0.14), I-2 = 89%, P = 0.02, NNT 13] and in the subgroup "" liquid diet on day before"" [MH RE, RD 0.14, IC (0.06,0.22), P = 0.0006, I-2 = 81%, NNT 8]. SPMC was also found to cause fewer adverse events than PEG in the "" high-volume PEG solutions"" [MH RE, RD -0.18, IC (-0.30, -0.07), P = 0.002, I-2 = 79%, NNT 6] and PEG in the "" low-residue diet"" subgroup [MH RE, RD -0.17, IC (-0.27, 0.07), P = 0.0008, I-2 = 86%, NNT 6]. CONCLUSION SPMC seems to be better than PEG for bowel preparation, with a similar bowel cleaning success rate, better tolerability and lower prevalence of adverse events.
Palavras-chave
Sodium picosulphate, Polyethylene glycol, Bowel cleaning success, Tolerability, Colonoscopy, Randomized clinical trials, Meta-analysis
Referências
- Anastassopoulos K, 2016, DIGEST DIS SCI, V61, P2993, DOI 10.1007/s10620-016-4214-2
- Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
- Bechtold ML, 2016, ANN GASTROENTEROL, V29, P137, DOI 10.20524/aog.2016.0005
- Belsey J, 2012, ALIMENT PHARM THER, V35, P222, DOI 10.1111/j.1365-2036.2011.04927.x
- Bucci C, 2014, GASTROINTEST ENDOSC, V80, P566, DOI 10.1016/j.gie.2014.05.320
- Choi HS, 2016, J DIGEST DIS, V17, P268, DOI 10.1111/1751-2980.12337
- Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247
- Coronel M, 2017, J GASTROENTEROL PANC, P1
- de Moura Diogo Turiani, 2016, Rev Gastroenterol Peru, V36, P293
- Dik VK, 2015, GASTROINTEST ENDOSC, V81, P665, DOI 10.1016/j.gie.2014.09.066
- Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
- Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2
- Gweon TG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000628
- Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294
- Hassan C, 2013, ENDOSCOPY, V45, P142, DOI 10.1055/s-0032-1326186
- Heetun Z, 2016, IRISH J MED SCI, V185, P629, DOI 10.1007/s11845-015-1320-7
- Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
- Hoy SM, 2009, DRUGS, V69, P123, DOI 10.2165/00003495-200969010-00009
- Iberati A, 2009, BMJ-BRIT MED J, V339, pb2700, DOI 10.1136/BMJ.B2700
- Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
- Jeon SR, 2015, INT J COLORECTAL DIS, V30, P251, DOI 10.1007/s00384-014-2066-9
- Jin Z, 2016, EUR J CLIN PHARMACOL, V72, P523, DOI 10.1007/s00228-016-2013-5
- Johnson DA, 2014, GASTROENTEROLOGY, V147, P903, DOI 10.1053/j.gastro.2014.07.002
- Kang MS, 2014, INTEST RES, V12, P53, DOI 10.5217/ir.2014.12.1.53
- Kao D, 2011, CAN J GASTROENTEROL, V25, P657, DOI 10.1155/2011/486084
- Katz PO, 2013, AM J GASTROENTEROL, V108, P401, DOI 10.1038/ajg.2012.441
- Kim ES, 2014, SCAND J GASTROENTERO, V49, P871, DOI 10.3109/00365521.2014.910543
- Kim HG, 2015, GUT LIVER, V9, P494, DOI 10.5009/gnl14010
- Kim YS, 2014, DIS COLON RECTUM, V57, P522, DOI 10.1097/DCR.0000000000000066
- Kojecky V, 2012, GASTROENT HEPATOL, V66, P470
- Kojecky V, 2018, DIGEST LIVER DIS, V50, P271, DOI 10.1016/j.dld.2017.10.010
- Kojecky V, 2014, J GASTROINTEST LIVER, V23, P141
- Lawrance IC, 2011, ENDOSCOPY, V43, P412, DOI 10.1055/s-0030-1256193
- Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051
- Leitao K, 2014, ENDOSC INT OPEN, V2, pE230, DOI 10.1055/s-0034-1377520
- Lim YJ, 2014, WORLD J GASTROENTERO, V20, P2741, DOI 10.3748/wjg.v20.i11.2741
- Manes G, 2013, COLORECTAL DIS, V15, P1145, DOI 10.1111/codi.12246
- Martel M, 2015, GASTROENTEROLOGY, V149, P79, DOI 10.1053/j.gastro.2015.04.004
- Munoz-Navas M, 2015, INT J COLORECTAL DIS, V30, P1407, DOI 10.1007/s00384-015-2307-6
- Munsterman ID, 2015, EUR J GASTROEN HEPAT, V27, P29, DOI 10.1097/MEG.0000000000000192
- Navarro M, 2017, WORLD J GASTROENTERO, V23, P3632, DOI 10.3748/wjg.v23.i20.3632
- Parra-Blanco A, 2014, WORLD J GASTROENTERO, V20, P17709, DOI 10.3748/wjg.v20.i47.17709
- Pohl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126067
- Regev A, 1998, AM J GASTROENTEROL, V93, P1478, DOI 10.1111/j.1572-0241.1998.00467.x
- Regev A, 1996, GASTROINTEST ENDOSC, V43, P118
- Rex DK, 2002, AM J GASTROENTEROL, V97, P1696
- Rex DK, 2017, BEST PRACT RES CL GA, V31, P425, DOI 10.1016/j.bpg.2017.05.010
- Rex DK, 2014, GASTROINTEST ENDOSC, V80, P1113, DOI 10.1016/j.gie.2014.05.329
- Rex DK, 2013, GASTROINTEST ENDOSC, V78, P132, DOI 10.1016/j.gie.2013.02.024
- Ribeiro IB, 2018, ENDOSC INT OPEN, V6, pE558, DOI 10.1055/a-0591-2883
- Ruiz Zavala AM, 2016, ENDOSCOPIA, V28, P148
- Tan JJY, 2006, COLORECTAL DIS, V8, P247, DOI 10.1111/j.1463-1318.2006.00970.x
- THOMAS G, 1982, GASTROENTEROLOGY, V82, P435
- van Lieshout I, 2017, UNITED EUR GASTROENT, V5, P917, DOI 10.1177/2050640616684696
- Voiosu T, 2013, J GASTROINTEST LIVER, V22, P129
- Worthington J, 2008, CURR MED RES OPIN, V24, P481, DOI [10.1185/030079908X260844, 10.1185/030079908X260844 ]
- Xie QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099092
- Yoo IK, 2015, DIGEST LIVER DIS, V47, P131, DOI 10.1016/j.dld.2014.10.019